Bank of New York Mellon
GNMX

Bank of New York Mellon’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Bank of New York Mellon’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-27,317
Closed -$5K – 4329
2019
Q1 		$5K Sell
27,317
-798
-3% -$177 ﹤0.01% 4204
2018
Q4 		$20K Hold
28,115
– – ﹤0.01% 4158
2018
Q3 		$35K Hold
28,115
– – ﹤0.01% 4165
2018
Q2 		$31K Sell
28,115
-7,907
-22% -$12K ﹤0.01% 4142
2018
Q1 		$73K Buy
36,022
+7,907
+28% +$14.8K ﹤0.01% 4109
2017
Q4 		$34K Hold
28,115
– – ﹤0.01% 4251
2017
Q3 		$35K Hold
28,115
– – ﹤0.01% 4166
2017
Q2 		$37K Sell
28,115
-84,671
-75% -$122K ﹤0.01% 4174
2017
Q1 		$210K Buy
112,786
+149
+0.1% +$674 ﹤0.01% 3868
2016
Q4 		$583K Buy
112,637
+3,589
+3% +$18.9K ﹤0.01% 3520
2016
Q3 		$608K Buy
109,048
+5,891
+6% +$33.6K ﹤0.01% 3441
2016
Q2 		$572K Buy
103,157
+7,931
+8% +$41.6K ﹤0.01% 3454
2016
Q1 		$419K Buy
95,226
+18,138
+24% +$74.6K ﹤0.01% 3515
2015
Q4 		$464K Buy
77,088
+9,700
+14% +$65.9K ﹤0.01% 3558
2015
Q3 		$527K Buy
67,388
+8,391
+14% +$65K ﹤0.01% 3565
2015
Q2 		$361K Buy
58,997
+45,982
+353% +$356K ﹤0.01% 3731
2015
Q1 		$105K Buy
+13,015
New +$98.2K ﹤0.01% 4030

Other funds holding GNMX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AMCA
Arthur M. Cohen & Associates Northbrook, Illinois $640M AUM 26.68% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of New York Mellon's GNMX Position: Q2 2019 in Review

Bank of New York Mellon sold out of Aevi Genomic Medicine Inc (GNMX) in Q2 2019, closing a stake of 27,317 shares — an estimated $5K sold.

Bank of New York Mellon first reported a position in GNMX in Q1 2015 and held it in 17 quarters. The position peaked at $608K in Q3 2016. 29 funds tracked by Wall St. Rank hold GNMX as of Q2 2019.

  • Bank of New York Mellon reported no remaining Aevi Genomic Medicine Inc position as of Q2 2019 after selling out during the quarter.
  • Bank of New York Mellon sold 27,317 Aevi Genomic Medicine Inc shares in Q2 2019, an estimated $5K.
  • Bank of New York Mellon first reported a position in Aevi Genomic Medicine Inc in Q1 2015 and held it in 17 quarters.
  • Bank of New York Mellon's Aevi Genomic Medicine Inc position peaked at $608K in Q3 2016.
  • 29 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q2 2019.

Based on Bank of New York Mellon's 13F filing for Q2 2019, filed 12 Aug 2019.